You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Ecuador

Aug 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Ecuador with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Ecuador, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Ecuador for free:

The Consumer Health in Ecuador market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Ecuador?
  • What are the major brands in Ecuador?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Market performance recovery

Consumer health experienced stable value growth in 2010. This is attributed to recovery from the economic slowdown in 2009 as well as the habit among Ecuadorians to self-medicate. Mass media advertising for over the counter remedies is helping to boost the category and expand consumer awareness of the product benefits.

Sales restrictions lifted

Cold and flu remedies as well as antipyretic analgesics had temporarily been restricted by local health authorities because of the increase in the number of AH1N1 flu cases in 2009. The ban extended to advertising and promoting the afore-mentioned remedies. The measure was lifted during the third quarter in 2009 thus allowing chemists/pharmacies to openly sell such products, which also helped the main categories to recover in 2010.

Multinationals continued to dominate the Ecuadorian market in 2010

Multinationals widely dominate consumer health, with eight of the top 10 key players being multinationals. The substantial budgets for advertising and product positioning nationwide are the contributing factors behind the success of multinationals.

Chained chemists/pharmacies continue to increase distribution share

Chained chemists/pharmacies continued to actively launch promotions, discounts, and affiliation cards to attract consumers in 2010. Independent chemists/pharmacies, especially within urban areas, are being bought by major companies such as Farcomed or they opt to be part of a franchise such as Cruz Azul by Difare, which is more beneficial for independent chemists/pharmacies in terms of product availability and price.

Forecast performance

Over the forecast period 2010-2015, the consumer health market is expected to post a 4% constant value CAGR. Self-medication is one of the main factors driving growth as it is the preferred method due to the low incomes of Ecuadorians and a lack of a public hospital infrastructure, which encourages people to self-medicate and avoid the often prohibitive expense of visiting a doctor.

Table of Contents

Table of Contents

Consumer Health in Ecuador - Industry Overview

EXECUTIVE SUMMARY

Market performance recovery

Sales restrictions lifted

Multinationals continued to dominate the Ecuadorian market in 2010

Chained chemists/pharmacies continue to increase distribution share

Forecast performance

KEY TRENDS AND DEVELOPMENTS

Current Impact

Chained chemists/pharmacies continue their expansion in 2010

Generics are expected to gain market share over the forecast period

Herbal/traditional products gain penetration in the Ecuadorian market

MARKET DATA

  • Table 1 Sales of Consumer Health by Category: Value 2005-2010
  • Table 2 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 3 Consumer Health Company Shares 2006-2010
  • Table 4 Consumer Health Brand Shares 2007-2010
  • Table 5 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 6 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 7 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 8 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Generics

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Ecuador - Company Profiles

Carvagu SA in Consumer Health (Ecuador)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Grupo Farma del Ecuador SA in Consumer Health (Ecuador)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Grupo Farma del Ecuador SA: Competitive Position 2010

Laboratorio Farmacéutico Lamosan Cia Ltda in Consumer Health (Ecuador)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Laboratorio Farmacéutico Lamosan Cia Ltda : Competitive Position 2010

Adult Mouth Care in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Ecuadorians tend to self-medicate less in adult mouth care than in other consumer health categories. They will however self-medicate based on previous product experience or by consulting a pharmacist for conditions such as mouth ulcers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratorio Farmacéutico Lamosan Cia Ltda was the leading company in adult mouth care with a 44% value share in 2010. The company’s main brands are Gingivit and Topiden. Pfizer Cia Ltda ranked second in 2010 with a 20% share from its Oraldine brand. Quifatex SA held a 13% value share with its Pyralvex brand.

PROSPECTS

  • Adult mouth care is expected to experience a slight slowdown over the forecast period with a negative constant value CAGR of 0.3%. Although Ecuadorians are aware of oral hygiene, most mouth care remedies will continue to be prescribed or recommended by a dentist for special treatment. Middle- to high-income economic groups will continue to represent the main group of consumers for this category’s products.

CATEGORY DATA

  • Table 9 Sales of Adult Mouth Care: Value 2005-2010
  • Table 10 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 11 Adult Mouth Care Company Shares 2006-2010
  • Table 12 Adult Mouth Care Brand Shares 2007-2010
  • Table 13 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 14 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Aspirin, naproxen, acetaminophen and ibuprofen enjoy a high penetration in the Ecuadorian market thanks to the recognition of brands such as Aspirina, Apronax, Advil and Finalin Fem. Analgesic acceptance can be attributed to the persistent habit of self-medication among Ecuadorians, which is usually linked to their income capacity and a lack of public medical health infrastructure.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer HealthCare SA with its brands Apronax and Aspirina held a 45% value share in 2010. Bayer’s Apronax is the number one systemic analgesic with a 49% value share. In 2010, the company supported both brands with mass media advertising, in contrast to 2009 when advertising for analgesics was restricted.

PROSPECTS

  • Sales of analgesics are expected to experience at 3% constant value CAGR over the forecast period. The category will continue to benefit from Ecuadorians’ willingness to self-medicate; in addition, its high penetration rate will continue to underpin demand for major analgesic brands as their single unit prices are affordable to most Ecuadorians.

CATEGORY DATA

  • Table 15 Sales of Analgesics by Category: Value 2005-2010
  • Table 16 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 17 Analgesics Company Shares 2006-2010
  • Table 18 Analgesics Brand Shares 2007-2010
  • Table 19 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 20 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Current value growth in 2010 was higher than the review period CAGR. Growth was driven by increasing stress levels and busier lifestyles; companies such as Bayer del Ecuador and Genomma Lab Internacional SAB de CV have launched new products such as Eufytose and Dalay in order to capture part of this developing market.

SWITCHES

COMPETITIVE LANDSCAPE

  • Arkopharma, through its representative Zona Trade SA, launched its sleeping caps product, Insocaps, whose main components are Valerian and Humulus lupulus. Insocaps are distributed by Farcomed through its pharmacy brand Fybeca. Zona Trade is expected to increase its product presence by commercialising its brand Insocaps through other major distributors such as Difare.

PROSPECTS

  • Calming and sleeping products sales are expected to grow 4% in constant value terms over the forecast period. The segments growth will be driven by herbal traditional products. Companies such as Herbalife with its product line Relax Now, Sleep Now and GNC´s Sleep Formula brand were not sold through official channels in 2010. Both companies are expected to comply with product registration by the health body, Izquieta Perez in order to commercialise their brands in the future.

CATEGORY DATA

  • Table 21 Sales of Calming and Sleeping: Value 2005-2010
  • Table 22 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 23 Calming and Sleeping Company Shares 2006-2010
  • Table 24 Calming and Sleeping Brand Shares 2007-2010
  • Table 25 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 26 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Ecuador - Category Analysis

HEADLINES

TRENDS

  • The wide acceptance of such products continued in 2010, despite the ban until the end of the second quarter of 2010. Much of the category’s sales were driven primarily by UTC sales; chemist/pharmacy owners continued to sell to known customers. The category did not benefit from marketing efforts or from new product developments due to the sales and advertising ban in 2010.

SWITCHES

  • Summary 12 OTC Healthcare Switches 2008-2010

COMPETITIVE LANDSCAPE

  • Merck Ecuador CA leads the category with a42% value share in 2010. Novartis Ecuador SA ranked second in 2010 with an 18% value share. Merck Ecuador CA was ranked third with a 18% value share in 2010. Boehringer Ingelheim del Ecuador Cía Ltda ranked third with its brand Bisolvon and held a 14% value share in 2010

PROSPECTS

  • During 2011 to 2015, after the lifting of sales restrictions in the OTC market, Ecuadorian consumers will continue to purchase cough, cold and allergy (hay fever) remedies without medical prescription, contributing to overall sales growth. Demand will also continue to increase because of pollution intensifying in urban areas as well as climate change. These factors will increase respiratory ailments and will continue to boost category growth.

CATEGORY DATA

  • Table 27 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 28 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Increasing consumption at fast food restaurants and food courts, and poor hygiene conditions among lower- income groups have made stomach ailments more common in the country, especially in lower-income areas where sanitary conditions remain inadequate. In addition, busier lifestyles among professionals have resulted in unhealthy eating habits, such as eating fast food or skipping meals, which has caused an increase in digestive problems such as heartburn, among other digestive disorders.

SWITCHES

COMPETITIVE LANDSCAPE

  • Digestive remedies is concentrated mainly between three key multinationals. Pfizer Cia Ltda with a 21% value share leads digestive remedies with its brands Mylanta and Agarol. It is followed by Schering-Plough del Ecuador SA with its major brand Ditopax with a 15% value share. Meanwhile Boehringer Ingelheim del Ecuador Cía Ltda ranks third with a 13% value share with its brand Dulcolax which has a dual positioning as both antacid and antiflatulent. The brand comes in fruit- flavoured chewable tablets and is promoted with the tagline: “Para un control inmediato de la flatulencia y la acidez” (“For immediate control against flatulence and acidity”).

PROSPECTS

  • Sales of digestive remedies are expected to continue to grow over the forecast period, driven by the increasing trend towards consumers eating at food courts and fast food restaurants, in which hygienic conditions are not always optimal. Busier lifestyles and longer working hours will continue to boost the trend towards fast food or quick snacks such as sandwiches, benefiting sales of digestive remedies. Products with greatest acceptance will be those that offer rapid treatment of upset stomachs, heartburn or indigestion which are the most common stomach ailments in Ecuador.

CATEGORY DATA

  • Table 33 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 34 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 35 Digestive Remedies Company Shares 2006-2010
  • Table 36 Digestive Remedies Brand Shares 2007-2010
  • Table 37 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 38 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Lack of product knowledge and the use of analgesics for minor earache are the major factors behind category decline.

SWITCHES

COMPETITIVE LANDSCAPE

  • The market is largely fragmented with companies such as Farmayala SA competing with its Otozambon Gotas brand available at major chained health and beauty retailers such as Fybeca and Cruz Azul.

PROSPECTS

  • There were no significant new product developments during 2010 in Ecuadorian ear care. Typical formats in this category were very small rigid plastic bottles.

CATEGORY DATA

  • Table 39 Sales of Ear Care: Value 2005-2010
  • Table 40 Sales of Ear Care: % Value Growth 2005-2010
  • Table 41 Forecast Sales of Ear Care: Value 2010-2015
  • Table 42 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Allergy eye care, despite 3% growth in current value terms in 2010, represents a modest 4% share of total eye care sales, dominated almost entirely by standard eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer Cia Ltda remains the number one company in eye care and held a 37% value share with its brand Visina. Quifatex SA ranked second with a 26% value share with its products Refresh Tears, Satinique, Lerin and Refresh Celluvisc. GlaxoSmithKline Ecuador SA ranked third with a 25% share with its Eye Mo brand.

PROSPECTS

  • Eye care represents around 2% of the total consumer health market in Ecuador and is typically a non-essential product for most Ecuadorians as they mainly purchase eye care products through doctor prescriptions rather than OTC.

CATEGORY DATA

  • Table 43 Sales of Eye Care by Category: Value 2005-2010
  • Table 44 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 45 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 46 Eye Care Company Shares 2006-2010
  • Table 47 Eye Care Brand Shares 2007-2010
  • Table 48 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 49 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products posted current value growth of 8% in 2010. Demand is growing in Ecuador, mainly because of the increasing perception of natural products as a healthier option than standard remedies, moreover, the lack of prescriptions needed to purchase herbal remedies contributes to overall positive performance.

COMPETITIVE LANDSCAPE

  • Herbalife opened an office in Ecuador at the end of 2008 and is now commercialising its brands. In addition to protein drink powder mix in chocolate, strawberry and vanilla flavours, the company has also introduced an instant herbal beverage, performance protein powder and the skin care line Skin Activator.

PROSPECTS

  • Herbal/traditional products is expected to post a 5% CAGR in constant value terms over the forecast period. The forecast growth is anticipated to encourage new competitors and companies to target their strategies to expand their herbal products line in categories such as herbal/traditional analgesics, herbal/traditional tonics and bottled nutritive drinks and herbal/traditional digestive remedies.

CATEGORY DATA

  • Table 50 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 51 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 52 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 53 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care posted 6% current value growth, reaching sales of US$ 18.5 million in 2010. Its major category, antifungals, represents a 48% value share of total medicated skin care sales. Weather and humidity, especially in the coastal regions of the country, and seasonal changes during the winter rainy season are the driving factors that boost consumption.

SWITCHES

COMPETITIVE LANDSCAPE

  • Productos Avon Ecuador SA was the leading company in 2010 with an 13% value share with its acne treatment brand Clearskin. The company’s direct sales strategy to partner this brand with cosmetics purchases has proven successful to reaching a large portion of the population.

PROSPECTS

  • Sales of medicated skin care expected to increase over the forecast period, as tropical weather and humidity will continue to generate high incidence of dermatological problems particularly in coast regions. The most common skin care problems will continue to be athlete’s foot and other fungal outbreaks, thus topical antifungal products are expected to continue to drive sales performance over the forecast period.

CATEGORY DATA

  • Table 54 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 55 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 56 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 57 Medicated Skin Care Brand Shares 2007-2010
  • Table 58 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition in continues to be a relatively a small niche in the Ecuadorian market. Consumers of this type of product tend to be mostly sportsmen who frequently exercise at gyms and are looking to improve performance and body image. Consumption of sport nutrition products takes place primarily in Ecuador’s main cities Quito and Guayaquil, especially within middle-high and upper-income groups as they are able to afford such products.

COMPETITIVE LANDSCAPE

  • The sports nutrition category represents less than 1% of total consumer health value sales in Ecuador. GNC is the only brand with a significant presence, its sports nutrition products under the branded GNC are commercialised in GNC stores located in major malls and gyms.

PROSPECTS

  • Although sports nutrition is not significant in terms of overall consumer health, a 6% constant value CAGR is expected over the forecast period. Demand for sports nutrition will be driven by high-end consumer groups, especially males, with muscle-gaining products continuing to be the most important subcategory.

CATEGORY DATA

  • Table 60 Sales of Sports Nutrition: Value 2005-2010
  • Table 61 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 62 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 63 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 64 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 13 Sports Nutrition: Brand Ranking by Category 2010

Vitamins and Dietary Supplements in Ecuador - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements experienced 9% growth in current value terms in 2010. The category is very diverse with companies offering a wide range of vitamins and dietary supplements targeting different types of consumer needs and application. The improvement in overall performance is attributed mainly to the growth of key areas such as combination dietary supplements, calcium supplements, multivitamins and single vitamins (vitamin C).

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim del Ecuador Cía Ltda is the leading company with its brand Pharmaton and held a 17% value share in 2010. Ranked second was Bayer HealthCare SA with its brands Supradyn, Redoxon and Elevit which together held 12% of value sales. Merck Ecuador CA held fifth place with a 5% share with the company’s main brand Cebion.

PROSPECTS

  • Vitamins and dietary supplements is expected to post a 5% constant value CAGR over the forecast period. Growth will be boosted by strong advertising and product diversity, targeting different age groups and highlighting different benefits to reach a different niche such as energising, improving mental strength, and combating stress.

CATEGORY DATA

  • Summary 14 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 65 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 66 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 67 Dietary Supplements by Positioning 2006-2010
  • Table 68 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 69 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 70 Vitamins Brand Shares 2007-2010
  • Table 71 Dietary Supplements Brand Shares 2007-2010
  • Table 72 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 73 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Ecuador - Category Analysis

HEADLINES

TRENDS

  • The adoption of unhealthy eating habits driven by hectic lifestyles and lack of exercise have increased incidences of overweight among the Ecuadorian population, especially in main cities Quito and Guayaquil. There is an increase in the number of fast food restaurants, food courts and franchises offering meals at very affordable prices. It is expected that obesity rates will continue to growth, thus benefiting demand for weight management products in the country.

COMPETITIVE LANDSCAPE

  • No company or brand has a clear leadership in this environment due to a high level of fragmentation and no formal distribution.

PROSPECTS

  • Weight management products is expected to post a constant value CAGR of 4% over the forecast period. As influence on personal appearance continues, and obesity rates increase, especially in urban areas, demand for fast and effective slimming products will continue to rise, especially within middle-high and upper-income groups.

CATEGORY DATA

  • Table 74 Sales of Weight Management by Category: Value 2005-2010
  • Table 75 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 76 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 77 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Ecuador - Category Analysis

HEADLINES

TRENDS

  • A new entry into sticking plasters/adhesive bandages was 3M with its brand Nexcare, an innovative waterproof plaster for adults. The presentations come in circular shapes and squares. The company’s tagline: “Take care of what you love the most” features a mother taking care of her child with a plaster. The company targets plasters for children with branded plasters featuring popular characters such as Hanna Montana and Disney’s animated Cars characters, in an effort to compete with Beiersdorf’s Hansaplast, which features Disney characters and 3D pictures on its products.

COMPETITIVE LANDSCAPE

  • Beiersdorf´s Hansaplast was the brand leader with a 59% value share in 2010. Beiersdorf´s distribution is undertaken through traditional channels such as major distributors and direct sales to major supermarkets such as Supermaxi and Mi Comisariato in an attempt to reach more customers. Johnson & Johnson del Ecuador SA ranked second with a 14% share, followed closely by Grufarquímicas SA with a 13% share in 2010.

PROSPECTS

  • Zero growth in constant value terms is expected over the forecast period. Wound care is a nascent market in Ecuador mainly based on typical consumers’ guarded spending habits as the majority of the population is on a low income and prefer to use less specialised, but cheaper alternatives to wound care products such as disposable tissues and kitchen towels or cloths. Forecast growth is limited mainly to upper-income urban consumers.

CATEGORY DATA

  • Table 78 Sales of Wound Care by Category: Value 2005-2010
  • Table 79 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 80 Wound Care Company Shares 2006-2010
  • Table 81 Wound Care Brand Shares 2007-2010
  • Table 82 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 83 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report